Cardiac Abnormalities Seen in Pediatric Patients During the SARS-CoV2 Pandemic: An International Experience.
Bradley C Clark, Joan Sanchez-de-Toledo, Carles Bautista-Rodriguez...
https://pubmed.ncbi.nlm.nih.gov/32957826/Actively Recruiting
Led by Medical University of Warsaw · Updated on 2026-06-22
90
Participants Needed
1
Research Sites
21 weeks
Total Duration
Multisystem inflammatory syndrome in children MIS-C is a serious condition linked to SARS-CoV-2 infection that often affects the heart and blood vessels. While many children recover quickly from acute heart problems, the long-term effects on cardiovascular health are not fully known. This study aims to evaluate heart and blood vessel health five years after MIS-C by comparing affected individuals with similar healthy controls using advanced tests and measurements. Participants include two groups those who had MIS-C and healthy children or young adults matched by age, sex, and body mass index. Each participant will undergo a thorough heart and vascular assessment including blood tests for endothelial injury markers, ultrasound of carotid arteries, heart ultrasound echocardiography, arterial stiffness measurements, and exercise testing on a cycle ergometer. The study focuses on measuring central aortic systolic blood pressure as the main outcome. Participants will attend a study visit approximately five years after MIS-C diagnosis where all assessments will be done. Researchers will compare various cardiovascular parameters, such as blood pressure, arterial stiffness, and exercise capacity, between the groups to identify any lasting abnormalities. This cross-sectional study will help improve understanding of long-term cardiovascular health after MIS-C and may guide future monitoring recommendations.
CONDITIONS
Cardiovascular Assessment 5 Years After MIS-C
W
Weronika Woźniak-Szewczyk, MD
M
Magdalena Okarska-Napierała, MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Medical University of Warsaw
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo blood tests, vascular and heart ultrasounds, arterial stiffness measurements, and exercise testing during a single study visit approximately five years after MIS-C diagnosis.
1 visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Bradley C Clark, Joan Sanchez-de-Toledo, Carles Bautista-Rodriguez...
https://pubmed.ncbi.nlm.nih.gov/32957826/Zahra Belhadjer, Mathilde Méot, Fanny Bajolle...
https://pubmed.ncbi.nlm.nih.gov/32418446/Elizabeth Whittaker, Alasdair Bamford, Julia Kenny...
https://pubmed.ncbi.nlm.nih.gov/32511692/Joseph Y Abrams, Matthew E Oster, Shana E Godfred-Cato...
https://pubmed.ncbi.nlm.nih.gov/33711293/Sylvia Krupickova, Carles Bautista-Rodriguez, Suzan Hatipoglu...
https://pubmed.ncbi.nlm.nih.gov/34798209/Jessica Flood, Joseph Shingleton, Emma Bennett...
https://pubmed.ncbi.nlm.nih.gov/34027512/Leora R Feldstein, Mark W Tenforde, Kevin G Friedman...
https://pubmed.ncbi.nlm.nih.gov/33625505/Medical University of Warsaw
Lead Sponsor